Our findings showed that HESS significantly improved lipid profiles in a dose dependent manner in L-NAME treated animals indicating that HESS inhibited hypertension by reducing inactivation of eNOS by LDL and promotion of its activity by improved HDL. This evidence concerns the gene NOS3 and hypertensive disorder.